Panacea Biotec - Quaterly Results

14 Nov 2022 Evaluate
The sales is pegged at Rs. 487.40 millions for the September 2022 quarter. The mentioned figure indicates a decline of about -59.13% as against Rs. 1192.60 millions during the year-ago period.The Net Loss for the quarter ended September 2022 is Rs. -68.50 millions as compared to Net Loss of Rs. -223.70 millions of corresponding quarter ended September 2021 Operating profit Margin for the quarter ended September 2022 improved to 16.00% as compared to -139.80% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 487.40 1192.60 -59.13 1100.80 1555.20 -29.22 2355.00 3435.60 -31.45
Other Income 79.20 34.70 128.24 144.50 76.20 89.63 125.70 207.40 -39.39
PBIDT 16.00 -139.80 -111.44 -638.90 -292.40 118.50 -601.10 212.40 -383.00
Interest 22.10 19.10 15.71 46.80 36.90 26.83 70.40 75.20 -6.38
PBDT -6.10 -158.90 -96.16 -685.70 -329.30 108.23 -671.50 137.20 -589.43
Depreciation 62.40 64.80 -3.70 125.20 129.10 -3.02 264.30 265.70 -0.53
PBT -68.50 -223.70 -69.38 -810.90 -458.40 76.90 -935.80 -128.50 628.25
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.60 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -7.10 0.00
PAT -68.50 -223.70 -69.38 -810.90 -458.40 76.90 -935.80 -144.10 549.41
Equity 61.30 61.30 0.00 61.30 61.30 0.00 61.30 61.30 0.00
PBIDTM(%) 3.28 -11.72 -128.00 -58.04 -18.80 208.70 -25.52 6.18 -512.86

Panacea Biotec Share Price

120.40 -3.05 (-2.47%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.